AstraZeneca stock holds firm as revenue and EPS beat estimates
Published on 08/29/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AstraZeneca plc stock is anchored by a July 27, 2026 earnings update that showed $15.38 billion in quarterly revenue and $2.63 in adjusted EPS, while the market value stood at $255.18 billion on August 28, 2026.
Earnings stay the anchor
In the quarter ended June 30, 2026, revenue rose 6.4% year over year from $14.45 billion, and EPS topped the $2.50 estimate by $0.13. The same report showed a net margin of 17.02%, with return on equity at 31.45%.
Sell-side expectations still point to $10.21 in full-year EPS, which frames the next set of updates for investors watching the shares.
Market value and range
The stock traded in a $161.18 to $163.54 intraday range on August 28, 2026, against a 52-week span of $146.10 to $212.71. That keeps the name below its one-year high while the market cap remains above $255 billion.
AstraZeneca's valuation also sits alongside a debt-to-equity ratio of 0.47 and a quick ratio of 0.67 in the latest market snapshot, signaling a large-cap pharma profile that is still being judged on execution rather than multiple expansion.
What the product mix supports
The company's oncology and rare-disease portfolio remains central to the case, because those franchises carry the revenue base behind the July 2026 quarter and support the consensus view on full-year earnings.
That matters more than a single session's move. The shares were last quoted at $161.18 to $163.54 on August 28, 2026, with the market cap at $255.18 billion.
More on AstraZeneca plc
Company: AstraZeneca plc
ISIN: US6549022043
Ticker: AZN
Exchange: NYSE
Price (as of August 28, 2026): $161.18 to $163.54 USD
Market cap: $255.18 billion (as of August 28, 2026)
Sector / Industry: Health Care / Pharmaceuticals
Index membership: Nasdaq-100
AstraZeneca shares and the August 2026 view
AstraZeneca plc stock stays tied to a $255.18 billion market value, a $146.10 to $212.71 52-week range, and a July 27, 2026 quarter that delivered $15.38 billion in revenue and $2.63 in EPS.
